Background: Neuropeptide Y (NPY) is abundantly distributed in the mammalian nervous system. Its role in nociception arising from inflammatory and neuropathic pain conditions has been elucidated. However, its involvement in post-incisional nociception, particularly at the spinal cord level, is relatively unknown. Purpose: Management of postoperative pain is suboptimal. Evaluation of changes at the spinal level could facilitate better understanding of neural mechanisms underlying this type of pain. Methods: Rats were subjected to hind paw incision and spatiotemporal pattern of NPY expression in the dorsal horn was investigated by immunohistochemistry. Next, rats were implanted with intrathecal catheters using previously standardized procedure. NPY was injected into the intrathecal space by an indwelling catheter and behavioral assessment of nociception was performed. Results: Higher expression of NPY was observed in the superficial laminae of the dorsal horn. After incision, specific changes were observed like an abrupt decrease at 3 h after incision, which could be correlated with the intense nociception at this time. In contrast to morphine administration, which attenuated all 3 behavioral parameters of nociception, NPY decreased guarding behavior and thermal hyperalgesia during the acute phase. Conclusions: NPY is extensively expressed in the superficial laminae of the spinal cord and exhibit marked changes after incision. Nociception is also decreased after its administration. Hence, it is likely involved in post-incisional nociception. This information could have clinical relevance.

Keywords:
Analgesia, Central nervous system, Intra-spinal administration, Neuropeptides, Opioids
1.
Rae A: Reasons for delayed patient discharge following day surgery: a literature review. Nurs Stand 2016; 31: 42–51.
2.
Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, Carter T, Cassidy CL, Chittenden EH, Degenhardt E, Griffith S, Manworren R, McCarberg B, Montgomery R, Murphy J, Perkal MF, Suresh S, Sluka K, Strassels S, Thirlby R, Viscusi E, Walco GA, Warner L, Weisman SJ, Wu CL: Management of postoperative pain: a clinical practice guideline from the American pain society, the American society of regional anesthesia and pain medicine, and the American society of anesthesiologists’ committee on regional anesthesia, executive committee, and administrative council. J Pain 2016; 17: 131–157.
3.
Le Bars D, Gozariu M, Cadden SW: Animal models of nociception. Pharmacol Rev 2001; 53: 597–652.
4.
Todd AJ: Neuronal circuitry for pain processing in the dorsal horn. Nat Rev Neurosci 2010; 11: 823–836.
5.
Chibueze CE, et al: Spinal anaesthesia drugs for caesarean section. Cochrane Database Syst Rev 2016; 4:CD012134.
6.
Gangadharan V, Kuner R: Unravelling spinal circuits of pain and mechanical allodynia. Neuron 2015; 87: 673–675.
7.
Laing I, Todd AJ, Heizmann CW, Schmidt HH: Subpopulations of GABAergic neurons in laminae I-III of rat spinal dorsal horn defined by coexistence with classical transmitters, peptides, nitric oxide synthase or parvalbumin. Neuroscience 1994; 61: 123–132.
8.
Tatemoto K, Neuropeptide Y: History and overview; in Michel MC (ed): Neuropeptide Y and Related Peptides. Handbook of Experimental Pharmacology. Berlin, Springer, 2004, vol 162, pp 1–21.
9.
Klockars A, Levine AS, Olszewski PK: Hypothalamic integration of the endocrine signaling related to food Intake. Curr Top Behav Neurosci 2018, Epub ahead of print.
10.
Sayed S, Van Dam NT, Horn SR, Kautz MM, Parides M, Costi S, Collins KA, Iacoviello B, Iosifescu DV, Mathé AA, Southwick SM, Feder A, Charney DS, Murrough JW: A randomized dose-ranging study of neuropeptide Y in patients with posttraumatic stress disorder. Int J Neuropsychopharmacol 2018; 21: 3–11.
11.
Taylor BK, Fu W, Kuphal KE, Stiller CO, Winter MK, Chen W, Corder GF, Urban JH, McCarson KE, Marvizon JC: Inflammation enhances Y1 receptor signaling, neuropeptide Y-mediated inhibition of hyperalgesia, and substance P release from primary afferent neurons. Neuroscience 2014; 256: 178–194.
12.
Intondi AB, Dahlgren MN, Eilers MA, Taylor BK: Intrathecal neuropeptide Y reduces behavioral and molecular markers of inflammatory or neuropathic pain. Pain 2008; 137: 352–365.
13.
Yalamuri SM, Brennan TJ, Spofford CM: Neuropeptide Y is analgesic in rats after plantar incision. Eur J Pharmacol 2013; 698: 206–212.
14.
Intondi AB, Zadina JE, Zhang X, Taylor BK: Topography and time course of changes in spinal neuropeptide Y immunoreactivity after spared nerve injury. Neuroscience 2010; 165: 914–922.
15.
Brennan TJ, Vandermeulen EP, Gebhart GF: Characterization of a rat model of incisional pain. Pain 1996; 64: 493–501.
16.
Spofford CM, Ashmawi H, Subieta A, Buevich F, Moses A, Baker M, Brennan TJ: Ketoprofen produces modality-specific inhibition of pain behaviors in rats after plantar incision. Anesth Analg 2009; 109: 1992–1999.
17.
Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994; 53: 55–63.
18.
Allen JW, Yaksh TL: Assessment of acute thermal nociception in laboratory animals; in Luo ZD (ed): Pain Research: Methods and Protocols. NJ, Humana Press, 2004, pp 11–23.
19.
Malkmus SA, Yaksh TL: Intrathecal catheterization and drug delivery in the rat; in Luo ZD (ed): Pain Research: Methods and Protocols. NJ, Humana Press, 2004, pp 109–121.
20.
Ji RR, Zhang X, Wiesenfeld-Hallin Z, Hokfelt T: Expression of neuropeptide Y and neuropeptide Y (Y1) receptor mRNA in rat spinal cord and dorsal root ganglia following peripheral tissue inflammation. J Neurosci 1994; 14: 6423–6434.
21.
Ossipov MH, Zhang ET, Carvajal C, Gardell L, Quirion R, Dumont Y, Lai J, Porreca F: Selective mediation of nerve injury-induced tactile hypersensitivity by neuropeptide Y. J Neurosci. 2002; 22: 9858–9867.
22.
Polgár E, Sardella TC, Watanabe M, Todd AJ: Quantitative study of NPY-expressing GABAergic neurons and axons in rat spinal dorsal horn. J Comp Neurol 2011; 519: 1007–1023.
23.
Gautam M, Prasoon P, Kumar R, Reeta KH, Kaler S, Ray SB: Role of neurokinin type 1 receptor in nociception at the periphery and the spinal level in the rat. Spinal Cord 2016; 54: 172–182.
24.
Kaler S, Gupta S, Prasoon P, Gautam M, Ray SB: Role of calcitonin gene-related peptide in nociception resulting from hind paw incision in rats. J Anat Soc India 2017; 66: 7–14.
25.
Ray SB, Gupta H, Gupta YK: Up-regulation of mu-opioid receptors in the spinal cord of morphine-tolerant rats. J Biosci 2004; 29: 51–56.
26.
Szentagothai J: Neuronal and synaptic arrangement in the substantia gelatinosa rolandi. J Comp Neurol 1964; 122: 219–239.
27.
Sasek CA, Elde RP: Distribution of neuropeptide Y-like immunoreactivity and its relationship to FMRF-amide-like immunoreactivity in the sixth lumbar and first sacral spinal cord segments of the rat. J Neurosci 1985; 5: 1729–1739.
28.
Iwagaki N, Ganley RP, Dickie AC, Polgár E, Hughes DI, Del Rio P, Revina Y, Watanabe M, Todd AJ, Riddell JS: A combined electrophysiological and morphological study of neuropeptide Y-expressing inhibitory interneurons in the spinal dorsal horn of the mouse. Pain 2016; 157: 598–612.
29.
Mahinda TB, Taylor BK: Intrathecal neuropeptide Y inhibits behavioral and cardiovascular responses to noxious inflammatory stimuli in awake rats. Physiol Behav 2004; 80: 703–711.
30.
Taiwo OB, Taylor BK: Antihyperalgesic effects of intrathecal neuropeptide Y during inflammation are mediated by Y1 receptors. Pain 2002; 96: 353–363.
31.
Solway B, Bose SC, Corder G, Donahue RR, Taylor BK: Tonic inhibition of chronic pain by neuropeptide Y. Proc Natl Acad Sci U S A. 2011; 108: 7224–7229.
32.
Van den Pol AN: Neuropeptide transmission in brain circuits. Neuron 2012; 76: 98–115.
33.
Nusbaum MP, Blitz DM, Marder E: Functional consequences of neuropeptide and small-molecule co-transmission. Nat Rev Neurosci 2017; 18: 389–403.
34.
Dougherty PM, Staats PS: Intrathecal drug therapy for chronic pain: from basic science to clinical practice. Anesthesiol 1999; 91: 1891–1918.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.